Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp. (Nasdaq: EUCR) is a blank check company that filed an amended S-1 registration statement with the SEC on October 21, 2020, reflecting active progress through the IPO registration process during one of the busiest years on record for SPAC formations. Focused on the biomedical and life sciences sector, Eucrates was formed to identify and execute a business combination with a target company operating within healthcare or related industries. The S-1/A filing represents one of several disclosure milestones the company completed in 2020 as it prepared to begin its search for an acquisition target. For complete filing history, sponsor details, and deal analytics on EUCR and hundreds of other SPACs, sign up for full data access at SpacDesk.